HIV provider perspectives: The impact of stigma on substance abusers living with HIV in a rural area of the United States

AIDS Patient Care and STDs

Volumn 22, Issue 8, 2008, Pages 669-675

  Yannessa, John F ^a   Reece, Michael ^b   Basta, Tania B ^c  

^a Wall College of Business   (United States)

^b INDIANA UNIVERSITY   (United States)

^c OHIO UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; PATIENT REFERRAL; QUALITATIVE RESEARCH; RURAL HEALTH CARE; RURAL POPULATION; STIGMA; SUBSTANCE ABUSE; UNITED STATES;

ATTITUDE OF HEALTH PERSONNEL; HEALTH PERSONNEL; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; RURAL POPULATION; STEREOTYPING; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 50149121859     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2007.0151     Document Type: Article

References (49)

1. Glynn M, Rhodes P. Estimated HIV Prevalence in the United States at the End of 2003. Atlanta, GA: National HIV Prevention Conference, June 2005.
2. The Centers for Disease Control and Prevention. HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men - Five U.S. cities, June 2004 - April 2005. MMWR Morb Mortal Wkly Rep 2005;54:597-601.
3. Fordyce E, Thomas P, Shum R. Evidence of an increasing AIDS burden in rural America. Stat Bull Metrop Insur Co 1997;78:2-9.
4. Graham R, Forrester M, Wysong J, Rosenthal T, James A. HIV/AIDS in the rural United States: Epidemiologist and health services delivery. Med Care Res Rev 1995;52:435-452.
5. The Centers for Disease Control and Prevention. HIV/AIDS statistics and surveillance page. www.cdc.gov/hiv/topics/surveillance/resources/slides/urban- nonurban/index.htm (Last accessed August 3, 2007).
6. St. Lawrence J. Emerging behavioral strategies for the prevention of HIV in rural areas. J Rural Health 1999;15:335-343.
7. Schur C, Berk M, Dunbar J, Shapiro M, Cohn S, Bozzette S. Where to seek care: an examination of people in rural areas with HIV/AIDS. J Rural Health 2002;18:337-347.
8. Heckman T, Somlai J, Peters J, et al. Barriers to care among persons living with HIV/AIDS in urban and rural areas. AIDS Care 1998;10:365-375.
9. McKinney M. Variations in rural AIDS epidemiology and service delivery models in the United States. J Rural Health 2002;18:455-466.
10. Goffman E. Stigma: Notes on the Management of Spoiled Identity. New York: Simon & Schuster, 1963.
11. Chapple A, Ziebland S, McPherson A. Stigma, shame, and blame experienced by patients with lung cancer: A qualitative study. BMJ 2004;328:1470-1473.
12. Lichtenstein B, Hook EW, Sharma AK. Public tolerance, private pain: Stigma and sexually transmitted infections in the American Deep South. Cult Health Sex 2005;7:43-57.
13. Dovidio JF, Major B, Crocker J. Stigma: Introduction and overview. In: Heatherton TF, Kleck RE, Hebl MR, & Hull JG (eds). The Social Psychology of Stigma. New York, NY: Guilford Press, 2000:1-30.
14. Herek G, Capitanio J, Wideman K. HIV-related stigma and knowledge in the United States: Prevalence and Trends, 1991-1999. Am J Public Health 2002;92:371-377.
15. Herek G, Cogan J. Psychological sequelae of hate-crime victimization among lesbian, gay, and bisexual adults. J Consult Clin Psychol 1999;67:945-952.
16. Valdiserri R. HIV/AIDS stigma: An impediment to public health. Am J Public Health 2002;92:341-343.
17. Kinsler JJ, Wong MD, Sayles JN, Davis J, Cunningham WE. The effect of perceived stigma from a health care provider on access to care in low-income HIV-positive sample. AIDS Patient Care STDs 2007;21:584-592.
18. Golin C, Isasi F, Bontempi J, Eng E. Secret pills: HIV positive patients' experiences taking antiretroviral therapy in North Carolina. AIDS Educ Prev 2002;14:318-329.
19. Reif S, Golin S, Smith S. Barriers to accessing HIV/AIDS care in North Carolina: Rural and urban differences. AIDS Care 2005;17:558-565.
20. Reece M, Tanner A, Karpiak S, Coffey K. The impact of HIV-related stigma on HIV care and prevention providers. J HIV/AIDS Soc Serv 2007;6:55-73.
21. Galvan F, Burnam M, Bing E. Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people. J Psychoactive Drugs 2003;35(Suppl 1):153-160.
22. Atkinson J, Grant I. Natural history of neuropsychiatric manifestations of HIV disease. Psychiat Clin North Am 1994;17:17-33.
23. Blechner M. Psychodynamic approaches to the AIDS and HIV. In: Blechner MJ (ed.) Hope and Mortality: Psychodynamic Approaches to AIDS and HIV. Hillsdale, NJ: Analytic Press, 1997:140-176.
24. Burnham A, Bing E, Morton S, et al. Use of mental health and substance abuse treatment services among adults with HIV in the US. Arch Gen Psychiat 2001;58:729-736.
25. Kalichman S. Understanding AIDS. Washington, D.C.: American Psychological Association, 1998.
26. Perkins DO, Stern RA, Golden RN, Murphy C, Naftolowitz D, Evans DL. Mood disorders in HIV infection: Prevalence and risk factors in a non-epicentre of the AIDS epidemic. Am J Psychiatry 1994;151:233-236.
27. Reece M. HIV-related mental health care: Factors influencing dropout among low-income, HIV positive individuals. AIDS Care 2003;15:707-716.
28. Substance Abuse and Mental Health Services Administration. Mental Health HIV Services Collaborative Program. www.mentalhealth.samhsa.gov/publications/ allpubs/KEN02-0132/default.asp (Last accessed January 8, 2008).
29. Treisman G, Angelino AF, Hutton H. Psychiatric issues in the management of patients with HIV infection. JAMA 2001;286:2857-2864.
30. Whetten K, Reif S, Swartz M, et al. A brief mental health and substance abuse screener for persons with HIV. AIDS Patient Care STDs 2005;19:89-99.
31. Sherbourne CD, Hays RD, Fleishman JA, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiat 2000;157:248-254.
32. Singh N, Squier C. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care 1996;8:261-269.
33. Bartlett, JA. Addressing the challenges of adherence. J Acquir Immune Defic Syndr 2002;29(Suppl 1):S2-10.
34. Spire B, Duran S, Souville M, Leport C, Raffi F, Moatii JP. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: From a predictive to a dynamic approach. Soc Sci Med 2002;54:1481-1496.
35. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol 2000;19:123-133.
36. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2002;133:21-30.
37. Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV infected drug users. J Gen Intern Med 2000;17:377-380.
38. Turner BJ, Fleishman JA, Wenger N, et al. Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. J Gen Intern Med 2001;16:625-633.
39. Fairfield KM, Libman J, Davis RB, Eisenberg DM, Phillips RS. Delays in protease inhibitor use in clinical practice. J Gen Intern Med 1999;14:195-401.
40. Patton M. Qualitative Research & Evaluation Methods. Thousand Oaks: Sage, 2002.
41. Boyatzis R. Transforming Qualitative Information: Thematic Analysis and Code Development. Thousand Oaks, CA: Sage Publications, 1988.
42. Miles M, Huberman A. An expanded sourcebook: Qualitative Data Analysis. Thousand Oaks, CA: Sage Publications, 1994.
43. Brown L, Macintyre K, Trujillo L. Interventions to reduce HIV/AIDS stigma: What have we learned? AIDS Educ Prev 2003;15:49-69.
44. Cameron E. Legal Rights, Human Rights, and AIDS: The First Decade. Report from South Africa 2. AIDS Analysis Africa 1993;3:3-4.
45. Jayaraman K. Indian state plans compulsory AIDS testing, segregation, and branding. Nat Med 1998;4:378.
46. Zierler S, Cunningham W, Andersen R. Violence victimization after HIV infection in a probability sample of US adult clients in primary care. Am J Public Health 2000;90:208-215.
47. Herek G, Mitnick L, Burris S, et al. AIDS and stigma: A conceptual framework and research agenda. AIDS Public Policy J 1998;13:36-47.
48. Herek G, Capitanio J. Public reactions to AIDS in the United States: A second decade of stigma. Am J Public Health 1993;83:574-577.
49. Michels K, Hofman K, Keusch G, Hrynkow S. Stigma and global health: looking forward. Lancet 2006;9509:538-539.